ArticleDiabetes therapy : research, treatment and education of diabetes and related disorders2015

Assessing Bladder Cancer Risk in Type 2 Diabetes Clinical Trials: the Dapagliflozin Drug Development Program as a 'Case Study'.

Agata Ptaszynska et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.